Acquisition by Eric Hsu of 45000 shares of InMed Pharmaceuticals at 0.37 subject to Rule 16b-3

6670 Stock   307.50  3.00  0.99%   
Slightly above 50% of Fusheng Precision's sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in Fusheng Precision Co suggests that some traders are interested regarding Fusheng Precision's prospects. Fusheng Precision's investing sentiment can be driven by a variety of factors including economic data, Fusheng Precision's earnings reports, geopolitical events, and overall market trends.
Fusheng Precision stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fusheng daily returns and investor perception about the current price of Fusheng Precision Co as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by InMed Pharmaceuticals Officer Sr. Vp, Pre-clinical Resdev. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 45000 employee stock option (right to buy) at 0.37 of InMed Pharmaceuticals by Eric Hsu on 1st of May 2024. This event was filed by InMed Pharmaceuticals with SEC on 2023-12-23. Statement of changes in beneficial ownership - SEC Form 4

Fusheng Precision Fundamental Analysis

We analyze Fusheng Precision's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fusheng Precision using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fusheng Precision based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Fusheng Precision is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Fusheng Precision Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fusheng Precision stock to make a market-neutral strategy. Peer analysis of Fusheng Precision could also be used in its relative valuation, which is a method of valuing Fusheng Precision by comparing valuation metrics with similar companies.

Additional Tools for Fusheng Stock Analysis

When running Fusheng Precision's price analysis, check to measure Fusheng Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusheng Precision is operating at the current time. Most of Fusheng Precision's value examination focuses on studying past and present price action to predict the probability of Fusheng Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusheng Precision's price. Additionally, you may evaluate how the addition of Fusheng Precision to your portfolios can decrease your overall portfolio volatility.